G R Westerhof

1.0k total citations
25 papers, 912 citations indexed

About

G R Westerhof is a scholar working on Molecular Biology, Rheumatology and Hematology. According to data from OpenAlex, G R Westerhof has authored 25 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Rheumatology and 7 papers in Hematology. Recurrent topics in G R Westerhof's work include Folate and B Vitamins Research (15 papers), Biochemical and Molecular Research (8 papers) and Hematopoietic Stem Cell Transplantation (5 papers). G R Westerhof is often cited by papers focused on Folate and B Vitamins Research (15 papers), Biochemical and Molecular Research (8 papers) and Hematopoietic Stem Cell Transplantation (5 papers). G R Westerhof collaborates with scholars based in Netherlands, United States and United Kingdom. G R Westerhof's co-authors include Jan H. Schornagel, Gerrit Jansen, Ietje Kathmann, Gert Rijksen, Godefridus J. Peters, A L Jackman, John B. Hynes, B. Rademaker, Herbert M. Pinedo and Ronald A. Forsch and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemistry.

In The Last Decade

G R Westerhof

25 papers receiving 899 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G R Westerhof Netherlands 17 442 381 248 238 181 25 912
D. M. Moccio United States 16 393 0.9× 237 0.6× 133 0.5× 260 1.1× 289 1.6× 21 920
Katharine H. Dixon United States 8 360 0.8× 304 0.8× 84 0.3× 333 1.4× 144 0.8× 8 876
R. R. Bartlett Germany 19 435 1.0× 156 0.4× 100 0.4× 107 0.4× 72 0.4× 52 1.0k
Yuri Kamitsuji Japan 16 369 0.8× 174 0.5× 449 1.8× 223 0.9× 57 0.3× 32 929
L G Mendelsohn United States 14 481 1.1× 103 0.3× 44 0.2× 507 2.1× 78 0.4× 19 1.1k
Valérie Lagarde France 14 414 0.9× 295 0.8× 710 2.9× 254 1.1× 69 0.4× 27 1.2k
Monica Pallis United Kingdom 23 674 1.5× 43 0.1× 590 2.4× 509 2.1× 158 0.9× 61 1.3k
Antonella Gozzini Italy 22 752 1.7× 234 0.6× 1.0k 4.2× 408 1.7× 164 0.9× 75 1.7k
Rita Azevedo Portugal 21 529 1.2× 210 0.6× 88 0.4× 178 0.7× 144 0.8× 38 1.0k
Christina Cherian United States 15 465 1.1× 372 1.0× 70 0.3× 80 0.3× 72 0.4× 24 711

Countries citing papers authored by G R Westerhof

Since Specialization
Citations

This map shows the geographic impact of G R Westerhof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G R Westerhof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G R Westerhof more than expected).

Fields of papers citing papers by G R Westerhof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G R Westerhof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G R Westerhof. The network helps show where G R Westerhof may publish in the future.

Co-authorship network of co-authors of G R Westerhof

This figure shows the co-authorship network connecting the top 25 collaborators of G R Westerhof. A scholar is included among the top collaborators of G R Westerhof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G R Westerhof. G R Westerhof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ploemacher, Rob E., Kevin W. Johnson, Elwin Rombouts, et al.. (2004). Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model. Biology of Blood and Marrow Transplantation. 10(4). 236–245. 40 indexed citations
2.
Westerhof, G R, Julian D. Down, Irene V. van Blokland, et al.. (2001). O6-Benzylguanine potentiates BCNU but not busulfan toxicity in hematopoietic stem cells. Experimental Hematology. 29(5). 633–638. 15 indexed citations
3.
Westerhof, G R, Rob E. Ploemacher, A Boudewijn, et al.. (2000). Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.. PubMed. 60(19). 5470–8. 82 indexed citations
4.
Ploemacher, RE, et al.. (1999). Treosulfan as an alternative conditioning agent in bone marrow transplantation.. Blood. 94(10). 12 indexed citations
5.
Westerhof, G R, et al.. (1998). In vivo and in vitro sensitivity of murine bone marrow hemopoietic progenitors for treosulfan.. Data Archiving and Networked Services (DANS). 2 indexed citations
6.
Down, JD, G R Westerhof, A Boudewijn, Rita Setroikromo, & RE Ploemacher. (1998). Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice. Bone Marrow Transplantation. 21(4). 327–330. 23 indexed citations
7.
Westerhof, G R, Rob E. Ploemacher, & Julian D. Down. (1998). Maintaining High Levels of Syngeneic Bone Marrow Engraftment While Omitting Cyclophosphamide in Busulfan-Containing Conditioning Regimens. Blood. 92(4). 1462–1463. 2 indexed citations
8.
Jansen, Gerrit, Yehuda G. Assaraf, Hannah Sprecher, et al.. (1997). Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells. Advances in Enzyme Regulation. 37. 59–76. 22 indexed citations
9.
Westerhof, G R, Jan H. Schornagel, Ietje Kathmann, et al.. (1995). Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.. Molecular Pharmacology. 48(3). 459–471. 173 indexed citations
10.
Jansen, Gerrit, et al.. (1993). The Reduced Folate/Methotrexate Carrier and a Membrane-Associated Folate Binding Protein as Transport Routes for Novel Antifolates: Structure-Activity Relationships. Advances in experimental medicine and biology. 338. 767–770. 4 indexed citations
11.
Westerhof, G R, Jan H. Schornagel, S Rijnboutt, Herbert M. Pinedo, & Gerrit Jansen. (1993). Identification of a Reduced Folate/Methotrexate Carrier in Human KB-Cells Expressing High Levels of Membrane Associated Folate Binding Protein. Advances in experimental medicine and biology. 338. 771–774. 5 indexed citations
12.
Freisheim, James H., Manohar Ratnam, Frederick E. Williams, et al.. (1992). Molecular events in the membrane transport of methotrexate in human CCRF-CEM leukemia cell lines. Advances in Enzyme Regulation. 32. 17–31. 24 indexed citations
13.
Jansen, Gerrit, et al.. (1992). Measurement of folylpolyglutamate synthetase activity in head and neck squamous carcinoma cell lines and clinical samples using a new rapid separation procedure.. PubMed. 4(7). 299–305. 25 indexed citations
14.
Laan, Bernard F. A. M. van der, et al.. (1992). In vitro activity of novel antifolates against human squamous carcinoma cell lines of the head and neck with inherent resistance to methotrexate. International Journal of Cancer. 51(6). 909–914. 20 indexed citations
15.
Hynes, John B., G R Westerhof, Gerrit Jansen, et al.. (1991). Synthesis and biological evaluation of a fluorescent analog of folic acid. Biochemistry. 30(23). 5674–5681. 30 indexed citations
16.
Jansen, Gerrit, G R Westerhof, Ietje Kathmann, Gert Rijksen, & Jan H. Schornagel. (1991). Growth-inhibitory effects of 5,10-dideazatetrahydrofolic acid on variant murine L1210 and human CCRF-CEM leukemia cells with different membrane-transport characteristics for (anti)folate compounds. Cancer Chemotherapy and Pharmacology. 28(2). 115–117. 23 indexed citations
17.
Westerhof, G R, Gerrit Jansen, Ietje Kathmann, et al.. (1991). Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems.. PubMed. 51(20). 5507–13. 66 indexed citations
18.
19.
Jansen, Gerrit, G R Westerhof, Gert Rijksen, & Jan H. Schornagel. (1989). Interaction of N-hydroxy(sulfo)succinimide active esters with the reduced folate/methotrexate transport system from human leukemic CCRF-CEM cells. Biochimica et Biophysica Acta (BBA) - Biomembranes. 985(3). 266–270. 6 indexed citations
20.
Jansen, Gerrit, et al.. (1988). Expression of a membrane folate binding protein in human leukemic ccrf cem cells resistant to methotrexate by virtue of impaired transport. 29. 303. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. M. Moccio Breakdown of academic impact, for papers by Katharine H. Dixon Breakdown of academic impact, for papers by R. R. Bartlett Breakdown of academic impact, for papers by Yuri Kamitsuji Breakdown of academic impact, for papers by L G Mendelsohn Breakdown of academic impact, for papers by Valérie Lagarde Breakdown of academic impact, for papers by Monica Pallis Breakdown of academic impact, for papers by Antonella Gozzini Breakdown of academic impact, for papers by Rita Azevedo Breakdown of academic impact, for papers by Christina Cherian
Rankless by CCL
2026